Skip to content
IP + Technology Law
Home  »  News & Insights  »  Presentation

Prosecuting and Interpreting Claims Invoking Means Plus Function Interpretation in the United States – Knobbe Practice Webinar Series

March 18, 2022  | Mauricio Uribe and Keiji (Kenny) Masaki

Knobbe Practice Japan Webinar Series

Partner Mauricio Uribe provided an overview of means plus function claim limitations, focusing on prosecution of patent applications before the United States Patent and Trademark Office (USPTO). The discussion covered a review of  USPTO guidelines for characterizing and interpreting means plus function limitations in claims, tips for addressing USPTO interpretation of means plus function claims during prosecution, and sample claim language related to means plus function and covering various technology areas.

View live presentation: Video Link

View more webinars on our Vimeo home page: Knobbe Martens on Vimeo

View and download the full presentation below.
Knobbe Practice Webinar Series: Prosecuting and Interpreting Claims Invoking Means Plus Function Interpretation in the United States

View on SlideShare: Knobbe Practice Webinar Series: Prosecuting and Interpreting Claims Invoking Means Plus Function Interpretation in the United States

View more Knobbe Martens slide presentations here.

Prosecuting and Interpreting Claims Invoking Means Plus Function Interpretation in the United States – Knobbe Practice Webinar Series Headshot

Mauricio Uribe

Mauricio Uribe is the Co-Chair of the Software/IT and Electrical practice groups at Knobbe Martens. Mauricio has extensive experience in comprehensive client counseling in all aspects of intellectual property law....

Related Links

Practice Areas

News & Insights

Blog - Litigation
Jan 2025
No Patent-Like Claims Under State Law
BearBox, LLC, Austin Storms, v. Lancium LLC, Michael T. McNamara, Raymond E. Cline, Jr. Before Chen, Bryson, and Stoll. Appeal from United States District Court for the District of Delaware....
Blog - Medical Devices & Procedures
Jan 2025
Stryker Acquires Inari Medical for $4.9 Billion
Stryker Corporation (“Stryker”) recently announced that it has entered into a definitive agreement to acquire Inari Medical, Inc. (“Inari”) for approximately $4.9 billion. Inari develops technologies and products for treating pulmonary embolism, deep vein thrombosis, in-stent...
Publications
Jan 2025
Ari Feinstein and Andrea Cheek Author Article on Impact of Chevron Overturn in IP & Technology Law Journal
In the article “An Examination of the Impact of Chevron’s Death on Certain Intellectual Property Laws,” partners Ari Feinstein and Andrea Cheek explore the effects of the Supreme Court’s 2024...